WORK Medical Technology Group LTD - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K report covers the month of July 2025 for WORK Medical Technology Group LTD, a foreign private issuer headquartered in Hangzhou, China. The filing was submitted on July 15, 2025, and signed by Shuang Wu, Chief Executive Officer.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and capital structure rather than financial performance.
Material Changes
No material changes to financial performance or operations are disclosed in this document. The filing details the company's authorized share capital and current share issuance status as of the reporting date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items.
Key Facts for Investors
- Capital Structure: Authorized capital is US$250,000, divided into 400,000,000 Class A shares (1 vote each) and 100,000,000 Class B shares (20 votes each).
- Outstanding Shares: As of July 15, 2025, there are 48,942,082 Class A shares and 7,592,500 Class B shares issued and outstanding.
- Voting Rights: Class B shares hold significant voting power with 20 votes per share compared to 1 vote for Class A shares.
- Reporting Status: The company files annual reports under Form 20-F.